Zheyu Wang1, Chengling Li2, Wencai Huang3, Yan Chen1, Yuqiong Li2, Libin Huang3, Mei Zhang2, Dan Wu1, Li Wang3, Huilong Duan1, Jiye An1, Ning Deng4. 1. College of Biomedical Engineering and Instrument Science, The Ministry of Education Key Laboratory of Biomedical Engineering, Zhejiang University, Hangzhou, 310027, China. 2. The First People's Hospital of Yibin, Yibin, China. 3. ZICT Technology Co.,Ltd., Shenzhen, China. 4. College of Biomedical Engineering and Instrument Science, The Ministry of Education Key Laboratory of Biomedical Engineering, Zhejiang University, Hangzhou, 310027, China. zju.dengning@gmail.com.
Abstract
BACKGROUND: The prevalence of hypertension is high and increasing in China in recent years. The treatment and control of hypertension calls for long-term management beyond hospital, which is hard to implement in traditional care settings. Integrated care combined with information technology can promote high-quality healthcare services across the life-course. However, few studies have applied a customized integrated care model in community-based hypertension management in China, catering to the emerging "three-manager" mode. This study aims to identify the effectiveness of a pathway-driven eHealth-based integrated model that implemented as a full-featured telehealth system to facilitate standardized management of hypertension in China. METHODS: The trial has been designed as a 1-year, non-blinded superiority trial with two parallel groups. A total of 402 hypertensive patients who meet the eligibility criteria will be recruited and randomized with a 1:1 allocation. All the participants will receive a mobile device for self-management, which is a part of our telehealth system. Participants in the control group will only use the device for BP measurement and receive regular follow-ups from care providers according to the guidelines. Participants in the intervention group will gain full access to the system and receive intervention based on the proposed model (a well-designed coordinated care pathway consisting of 9 tasks). Outcomes will be measured mainly on three occasions (at inclusion, at 6 months, and at 12 months). The primary outcome is mean change in systolic blood pressure over a 12-month period. Secondary outcomes include changes in diastolic blood pressure, biochemical indexes related to hypertension, lifestyles, self-management adherence, and hypertension awareness, as well as work efficiency of care providers. DISCUSSION: This study aims to investigate whether a pathway-driven eHealth-based integrated care model based on the "three-manager" mode will improve hypertension control in China. Success of the model would help improve the quality of present community-based management procedures and benefit more patients with uncontrolled hypertension. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900027645 . Registered on November 22, 2019.
RCT Entities:
BACKGROUND: The prevalence of hypertension is high and increasing in China in recent years. The treatment and control of hypertension calls for long-term management beyond hospital, which is hard to implement in traditional care settings. Integrated care combined with information technology can promote high-quality healthcare services across the life-course. However, few studies have applied a customized integrated care model in community-based hypertension management in China, catering to the emerging "three-manager" mode. This study aims to identify the effectiveness of a pathway-driven eHealth-based integrated model that implemented as a full-featured telehealth system to facilitate standardized management of hypertension in China. METHODS: The trial has been designed as a 1-year, non-blinded superiority trial with two parallel groups. A total of 402 hypertensivepatients who meet the eligibility criteria will be recruited and randomized with a 1:1 allocation. All the participants will receive a mobile device for self-management, which is a part of our telehealth system. Participants in the control group will only use the device for BP measurement and receive regular follow-ups from care providers according to the guidelines. Participants in the intervention group will gain full access to the system and receive intervention based on the proposed model (a well-designed coordinated care pathway consisting of 9 tasks). Outcomes will be measured mainly on three occasions (at inclusion, at 6 months, and at 12 months). The primary outcome is mean change in systolic blood pressure over a 12-month period. Secondary outcomes include changes in diastolic blood pressure, biochemical indexes related to hypertension, lifestyles, self-management adherence, and hypertension awareness, as well as work efficiency of care providers. DISCUSSION: This study aims to investigate whether a pathway-driven eHealth-based integrated care model based on the "three-manager" mode will improve hypertension control in China. Success of the model would help improve the quality of present community-based management procedures and benefit more patients with uncontrolled hypertension. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900027645 . Registered on November 22, 2019.
Authors: Richard J McManus; Jonathan Mant; Emma P Bray; Roger Holder; Miren I Jones; Sheila Greenfield; Billingsley Kaambwa; Miriam Banting; Stirling Bryan; Paul Little; Bryan Williams; F D Richard Hobbs Journal: Lancet Date: 2010-07-08 Impact factor: 79.321
Authors: Sultan Baliz Erkoc; Burhanettin Isikli; Selma Metintas; Cemalettin Kalyoncu Journal: Int J Environ Res Public Health Date: 2012-03-22 Impact factor: 3.390
Authors: Perry M Gee; Deborah A Greenwood; Debora A Paterniti; Deborah Ward; Lisa M Soederberg Miller Journal: J Med Internet Res Date: 2015-04-01 Impact factor: 5.428